Britain Canada Eu European Union United Kingdom Coronavirus Britain Canada Eu

AstraZeneca defends COVID-19 vaccine, says ‘no evidence’ of increased risk of blood clots

Reading now: 244
globalnews.ca

AstraZeneca Plc on Sunday said it had conducted a review of people vaccinated with its COVID-19 vaccine which has shown no evidence of an increased risk of blood clots.The review covered more than 17 million people vaccinated in the European Union and United Kingdom.“A careful review of all available safety data of more than 17 million people vaccinated in the European Union and UK with COVID-19 Vaccine AstraZeneca has shown no evidence of an increased risk of pulmonary embolism, deep vein thrombosis or thrombocytopenia, in any defined age group, gender, batch or in any particular country,” the statement said.Global News has reached out to see if Health Canada was considering halting its AstraZeneca vaccine rollout or had requested any.

Read more on globalnews.ca
The website covid-19.rehab is an aggregator of news from open sources. The source is indicated at the beginning and at the end of the announcement. You can send a complaint on the news if you find it unreliable.

Related News